When a single molecule is proposed to help the liver, the vasculature, the nervous system, and the aging process all at once, the breadth of the claim is itself a reason for caution, not enthusiasm: broad, database-derived promise is exactly the kind of signal that most often fails to survive controlled testing
(iv) absence of progression of local oedema or ecchymosis for at least 24 h
Full AI Image Prompt: Create a clean medical infographic titled GHK-Cu Claim Strength Matrix. Use a two-axis matrix with the horizontal axis labeled Evidence strength and the vertical axis labeled Claim scope. Place labeled cards: Topical skin aging, Wound-care context, Hair growth, Injectable regeneration, and Systemic anti-aging. Position topical skin aging and wound-care context closer to stronger evidence, hair growth in a limited or indirect evidence area, and injectable regeneration and systemic anti-aging in an uncertain evidence-gap area
Statistical analyses were performed separately for maternal blood at inclusion and delivery, and venous and arterial umbilical cord blood
The Whickham Survey
While GHK-Cu represents an area of ongoing scientific research, it should not be viewed as a replacement for clinically validated treatments
